| Literature DB >> 35807109 |
Karolina Chilicka1, Aleksandra M Rogowska2, Renata Szyguła1, Monika Rusztowicz1, Danuta Nowicka3.
Abstract
There are many cosmetic methods to reduce skin eruptions in people with acne vulgaris. As oxybrasion is a safe method of exfoliating dead epidermis, our objective was to investigate its effectiveness in young women with acne vulgaris. The Global Acne Grading System (GAGS) and Derma Unit SSC 3 device (Sebumeter SM 815, Corneometer CM 825) were used to assess acne vulgaris and skin properties. Twenty-four women aged 19-21 years (M = 19.50, SD = 0.66) with diagnosed mild acne vulgaris and a high level of sebum (more than 100 μg/cm2) participated in the study. Women on any dermatological treatment within the last 12 months and/or hormonal contraception were excluded. Probands were randomly assigned to two equal groups. Group A (experimental) was oxybrased with 0.9% sodium chloride solution simultaneously with compressed oxygen. Group B (placebo) was the group treated with non-carbonated mineral water and oxygen from the device (not pure). A series of five treatments was performed at 10-day intervals. Skin parameters were measured before and 30 days after the end of treatment. As a result, in group A (experimental), skin hydration and GAGS improved, while sebum on the epidermis was reduced. No side effects were noted. We concluded that oxybrasion is effective in women with acne and safe, as it improved skin parameters; however, further research is needed.Entities:
Keywords: acne vulgaris; corneometer; oxybrasion; sebumeter
Year: 2022 PMID: 35807109 PMCID: PMC9267691 DOI: 10.3390/jcm11133824
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Patient follow in the study.
Descriptive statistics.
| Variable | Total Sample | Group A | Group B |
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||
| Age | 19.50 | 0.66 | 19.25 | 0.45 | 19.75 | 0.75 | −1.97 | 0.062 | −0.80 |
| Years of acne | 5.79 | 0.83 | 5.42 | 0.67 | 6.17 | 0.84 | −2.43 | 0.024 | −0.99 |
| GAGS before | 17.08 | 0.88 | 17.17 | 1.03 | 17.00 | 0.74 | 0.46 | 0.653 | 0.19 |
| GAGS after | 12.75 | 3.97 | 9.00 | 1.13 | 16.50 | 1.00 | −17.23 | <0.001 | −7.04 |
Note. Group A = experimental, Group B = placebo, GAGS = Global Acne Grading System, M = mean, SD = standard deviation, t = Student’s t-test, p = significance level, d = Cohen’s d effect size.
Figure 2Effect of treatment on acne severity in two patients from group A (experimental) before (a,b) and after treatment (a,b).
Figure 3Effect of treatment on acne severity in two patients from group B (placebo) before (a,b) and after treatment (a,b).
The repeated measures one-way ANOVA for moisturizing using Corneometer CM825 (g/m2).
| Moisturizing | Group A | Group B | Effect |
| η2 | |||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
|
| G | 2.61 | 0.120 | 0.11 | ||||
| Before | 41.69 | 5.63 | 41.87 | 6.30 | T | 44.26 | <0.001 | 0.67 |
| After | 49.81 | 5.44 | 42.18 | 6.01 | T × G | 37.86 | <0.001 | 0.63 |
|
| G | 1.27 | 0.272 | 0.06 | ||||
| Before | 41.93 | 6.92 | 43.58 | 6.45 | T | 30.87 | <0.001 | 0.58 |
| After | 51.54 | 5.15 | 44.50 | 6.54 | T × G | 21.05 | <0.001 | 0.49 |
|
| G | 0.69 | 0.416 | 0.03 | ||||
| Before | 41.61 | 8.54 | 41.97 | 8.07 | T | 43.92 | <0.001 | 0.67 |
| After | 49.03 | 7.41 | 43.34 | 8.09 | T × G | 20.74 | <0.001 | 0.49 |
|
| G | 1.23 | 0.279 | 0.05 | ||||
| Before | 43.72 | 8.03 | 43.63 | 7.89 | T | 20.57 | <0.001 | 0.48 |
| After | 50.77 | 7.97 | 44.23 | 6.33 | T × G | 14.62 | <0.001 | 0.40 |
|
| G | 0.09 | 0.766 | 0.00 | ||||
| Before | 38.98 | 4.62 | 40.84 | 5.58 | T | 3.61 | 0.071 | 0.14 |
| After | 41.30 | 4.57 | 40.71 | 6.34 | T × G | 4.54 | 0.045 | 0.17 |
Note. Group A = experimental, Group B = placebo, G = group, T = treatment. M = mean, SD = standard deviation, F = Fisher’s F-test, p = significance level, η2 = partial eta-square effect size.
The repeated measures one-way ANOVA for greasing using Sebumeter SM815 (μg/cm2).
| Greasing | Group A | Group B | Effect |
| η2 | |||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
|
| G | 12.8 | 0.002 | 0.37 | ||||
| Before | 187.08 | 30.73 | 191.08 | 28.86 | T | 146.8 | <0.001 | 0.87 |
| After | 115.08 | 24.92 | 185.75 | 21.47 | T × G | 109.1 | <0.001 | 0.83 |
|
| G | 9.1 | 0.006 | 0.29 | ||||
| Before | 180.08 | 23.17 | 180.42 | 22.70 | T | 87.4 | <0.001 | 0.80 |
| After | 124.42 | 16.42 | 174.67 | 24.93 | T × G | 57.7 | <0.001 | 0.72 |
|
| G | 7.4 | 0.013 | 0.25 | ||||
| Before | 182.75 | 27.74 | 178.33 | 26.05 | T | 130.2 | <0.001 | 0.86 |
| After | 112.83 | 18.91 | 170.83 | 28.27 | T × G | 84.6 | <0.001 | 0.79 |
|
| G | 9.1 | 0.006 | 0.29 | ||||
| Before | 180.92 | 24.35 | 181.25 | 23.03 | T | 58.3 | <0.001 | 0.73 |
| After | 125.00 | 13.12 | 171.42 | 24.37 | T × G | 28.6 | <0.001 | 0.57 |
|
| G | 1.0 | 0.334 | 0.04 | ||||
| Before | 180.17 | 19.63 | 165.92 | 25.34 | T | 78.0 | <0.001 | 0.78 |
| After | 129.75 | 12.62 | 160.00 | 25.15 | T × G | 48.7 | <0.001 | 0.69 |
Note. Group A = experimental, Group B = placebo, G = group, T = treatment. M = mean, SD = standard deviation, F = Fisher’s F-test, p = significance level, η2 = partial eta-square effect size.